GMTA is the Global Medical Technology Alliance. Its members are national or regional medical technology associations, which represent innovative companies that currently develop and manufacture 85 percent of the world's medical devices, diagnostics and equipment. It provides a forum for the development and advocacy of policies that support innovation in medical technology to address patients' healthcare needs. Medical technologies save, support, and improve lives every day around the world. 

The Global Medical Technology Alliance (GMTA) member associations represent companies that produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our represented companies produce nearly 85 percent of the health care technology purchased and utilised annually around the world. Our companies range from the largest to the smallest innovators and bring medical technology to patients around the world in every setting.

Mission: Members of the Global Medical Technology Alliance (GMTA) support the objectives of providing safe, effective and innovative medical technology that saves and enhances lives, benefiting people and society. The GMTA is a forum in which members exchange information and jointly develop and advocate policies that encourage innovation to address patients' healthcare needs.

Objectives: The objects or purpose of GMTA include:

• Development and dissemination of information pertaining to medical technology policies and issues on a global basis
• Coordination of common policy positions for effective representation at a global level of the medical technology industry, generally and in forums such as World Health Organization (WHO), World Bank (WB), World Intellectual Property Organization (WIPO), and World Trade Organization (WTO)
• Encouragement of an international policy environment that supports the development of the medical technology industry, including harmonised regulatory systems, appropriate payment levels, efficient coverage determination systems, patient access to medical technologies, and a strong intellectual property system to support technology research and development and promote equitable access to medical devices
• Promotion of, and support for, principles of ethical conduct and practices in the marketing and distribution of medical technology products
• Liaison with other international bodies such as patient associations and professional societies, and
• Support for, and/or liaison with, international collaborative forums that can advance the GMTA Mission, such as the Global Harmonization Task Force (GHTF), the Global Medical Device Nomenclature Agency (GMDN), Asian Harmonization Working Party (AHWP), Latin American Harmonization Working Party (LAHWP), Health Technology Assessment International (HTAi), and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).